Behind the heterogeneity in the long-term course of first-episode psychosis: Different psychotic symptom trajectories are associated with different patterns of cannabis and stimulant use
Authors:
Open Access
- 16 July 2024
- journal article
- research article
- Published by Elsevier in Schizophrenia Research
- Vol. 271, 91-99
Abstract
No abstract availableKeywords
All Related Versions
This publication has 48 references indexed in Scilit:
- 20-Year trajectories of six psychopathological dimensions in patients with first-episode psychosis: Could they be predicted?Psychiatry Research, 2023
- Clinical Recovery and Long-Term Association of Specialized Early Intervention Services vs Treatment as Usual Among Individuals With First-Episode Schizophrenia Spectrum DisorderJAMA Psychiatry, 2023
- Linear Regression2021
- Cannabis use and psychosis: a review of reviewsEuropean Archives of Psychiatry and Clinical Neuroscience, 2019
- Cannabis-associated psychosis: Neural substrate and clinical impactNeuropharmacology, 2017
- Symptomatic and functional outcomes of substance use disorder persistence 2 years after admission to a first-episode psychosis programPsychiatry Research, 2017
- An Integrative Perspective on the Role of Dopamine in SchizophreniaBiological Psychiatry, 2017
- Association Between Continued Cannabis Use and Risk of Relapse in First-Episode PsychosisJAMA Psychiatry, 2016
- Relationship between cannabis and psychosis: Reasons for use and associated clinical variablesPsychiatry Research, 2015
- Early detection, early symptom progression and symptomatic remission after ten years in a first episode of psychosis studySchizophrenia Research, 2013